{
    "title": "107_hr3160",
    "content": "The Act may be cited as the \"Bioterrorism Prevention Act of 2001\" and includes an expansion of the biological weapons statute. The \"Bioterrorism Prevention Act of 2001\" expands the biological weapons statute by amending Section 175 of title 18, United States Code to include penalties for reckless handling of select agents. This includes fines, imprisonment for up to one year, or both for those who possess, use, or control select agents in a manner that endangers public health and safety. The \"Bioterrorism Prevention Act of 2001\" amends Section 175 of title 18, United States Code to include penalties for violations related to biological agents or toxins. This includes fines, imprisonment for up to 10 years, or both for causing bodily injury, and fines or imprisonment for possessing unregistered select agents. The Bioterrorism Prevention Act of 2001 imposes penalties for transferring select agents without proper registration, shipping or possessing select agents illegally, with fines, imprisonment for up to 5 years, or both. The Bioterrorism Prevention Act of 2001 imposes penalties for illegal possession or transfer of select agents, with fines, imprisonment for up to 5 years, or both. Section 175 of title 18, United States Code, defines terms related to biological agents, toxins, and bodily injury for use as weapons. The Bioterrorism Prevention Act of 2001 prohibits possession of biological agents, toxins, or delivery systems for non-peaceful purposes. A 'restricted person' is defined as someone listed in section 922(g) or an alien not lawfully admitted for permanent residence. The Secretary of Health and Human Services designates categories of aliens who are not considered restricted persons. The Secretary of Health and Human Services, in consultation with the Attorney General, may designate categories of individuals with nonimmigrant visas and expertise valuable to the United States regarding select agents. A 'select agent' is a biological agent or toxin on a specific list and not exempted from regulations. The Secretary of Health and Human Services, in consultation with the Attorney General, may designate categories of individuals with nonimmigrant visas and expertise valuable to the United States regarding select agents. This designation takes effect upon the expiration of the 90-day period after the enactment of the Act, with regulations to be determined within 30 days. The Secretary, in consultation with the Attorney General, may designate categories of individuals with nonimmigrant visas and expertise valuable to the United States regarding select agents. An interim final rule must be promulgated within 60 days after enactment. Section 175(a) of title 18, United States Code, is amended. Amendments to the Antiterrorism and Effective Death Penalty Act of 1996 include striking subsection (f) and redesignating subsection (g). The Secretary, in consultation with the Attorney General, may designate categories of individuals with nonimmigrant visas and expertise valuable to the United States regarding select agents. An interim final rule must be promulgated within 60 days after enactment. Section 175(a) of title 18, United States Code, is amended. Amendments to the Antiterrorism and Effective Death Penalty Act of 1996 include regulations for the possession and use of listed biological agents and toxins to prevent terrorism or criminal activities. The Secretary of Health and Human Services must promulgate an interim final rule within 30 days after the enactment of the Act for registration requirements of biological agents and toxins. The rule takes effect 60 days after promulgation. The interim final rule for registration requirements of biological agents and toxins must be promulgated within 30 days of the Act's enactment. The rule will take effect 60 days after promulgation, with specified penalties for non-compliance. The Act requires individuals in possession of listed biological agents or toxins to apply for registration within 30 days of the promulgation of the interim final rule. The Act mandates registration for individuals with listed biological agents or toxins within 30 days. Information identifying registered persons or site-specific details shall not be disclosed under section 552(a) of title 5, US Code. The amendment allows Federal agencies to disclose information for public health and safety purposes or to Congress upon request. The effective date aligns with the final rule issued under the Antiterrorism and Effective Death Penalty Act of 1996. Civil penalties are also amended under the Act. The amendment allows for civil penalties up to $250,000 for individuals and $500,000 for others who violate regulations under subsections (e) or (f). Section 511 of the Antiterrorism and Effective Death Penalty Act of 1996 is amended to clarify the scope of the select agent rule to include toxins. The amendment clarifies the scope of the select agent rule to include toxins and allows for civil penalties for violations. Effective date for the amendments is retroactive to the Antiterrorism and Effective Death Penalty Act of 1996. The amendment expands the select agent rule to include toxins and allows for civil penalties for violations. It also makes conforming amendments to the Antiterrorism and Effective Death Penalty Act of 1996. The amendment expands the select agent rule to include toxins and allows for civil penalties for violations. The Secretary of Health and Human Services must report to Congress on compliance with regulations under the Antiterrorism and Effective Death Penalty Act of 1996. The Secretary of Health and Human Services must report to Congress on compliance with regulations under section 511, future plans for enforcement, and any recommendations for administrative or legislative initiatives. The House of Representatives passed the legislation on October 23, 2001."
}